AZO vs EDIT
AutoZone Inc (AZO) versus Editas Medicine Inc (EDIT) — a side-by-side from cached financials, not a winner call.
AutoZone Inc (AZO) is a auto parts company listed on NYSE.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Latest reported AZO revenue for 2025-08-30 was $18.94B. Net income was $2.50B. Revenue was up 2.4% from 2024-08-31 to 2025-08-30. AZO currently screens at market cap $50.08B and trailing P/E 21.0.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
AZO currently screens at market cap $50.08B and trailing P/E 21.0. EDIT currently screens at market cap $375.2M.
Not investment advice. Open the AZO and EDIT stock pages for the full models.
Not investment advice.